Reversing Ischemic Strokes: What Are The Options?

Ischemic stroke, also known as brain ischemia or cerebral ischemia, is a medical emergency caused by a blockage in a blood vessel supplying blood to the brain. It is the most common type of stroke, accounting for about 87% of all stroke cases. The blockage is often caused by blood clots or fatty deposits inside the blood vessel, leading to oxygen starvation and the death of neurons.

While strokes are a leading cause of death and disability, they can be reversed if timely and competent treatment is administered. The first goal of treatment is to restore blood flow to the affected area of the brain, typically through the use of intravenous tissue plasminogen activator (tPA), a medication that breaks up blood clots. This treatment is most effective when given within 4 hours of the first symptoms. In some cases, blood clots may be removed through surgery or mechanical thrombectomy, which can be performed up to 24 hours after the onset of stroke symptoms.

To reverse the secondary effects of a stroke, rehabilitation is necessary. This involves physical, occupational, and speech therapy to help patients regain motor skills, coordination, and speech abilities. The brain's natural ability to rewire itself, known as neuroplasticity, plays a crucial role in recovery. Through consistent and intensive rehabilitation, partial or even full recovery is possible.

Research is ongoing to develop new therapeutic techniques for reversing stroke-induced damage. A USC-led study found that a combination of human stem cells and a special protein, 3K3A-APC, showed promising results in repairing stroke damage in mice. Clinical trials are needed to determine the effectiveness of this approach in humans.

The importance of early treatment

Ischemic stroke is a medical emergency that requires immediate attention. The condition occurs when a blood vessel supplying blood to the brain is blocked, often by a blood clot or fatty deposits. As a result, the affected region of the brain is deprived of oxygen-rich blood, leading to cell death and potential brain damage. The faster the blockage is addressed, the better the chances of recovery without permanent damage. Here's why early treatment is crucial:

Timely Intervention Improves Outcomes

The first few hours after the onset of stroke symptoms are critical. Seeking medical care within 2–3 hours is vital as it improves the chances of recovery and reduces the likelihood of permanent disability. The "time is brain" principle emphasizes that prompt treatment can prevent irreversible brain damage.

Early Treatment Options

The initial goal of treatment is to restore blood flow to the affected area of the brain. This can be achieved through the use of intravenous tissue plasminogen activator (tPA), a medication that breaks up blood clots. tPA is most effective when administered within 4 hours of the first symptoms. Beyond this window, alternative treatment options may be considered.

Preventing Further Damage

Quick detection of stroke symptoms and timely treatment are crucial to minimize damage to the brain. Until the blockage is addressed, the lack of blood flow continues to cause harm. Early treatment helps to stop the progression of the stroke and prevents further brain tissue damage.

Enhancing Recovery

Early treatment sets the stage for a better recovery process. It reduces the severity of the stroke and the extent of brain damage, making the rehabilitation process more effective. Rehabilitation teaches the healthy parts of the brain to compensate for the damaged areas, and early intervention enhances the brain's ability to adapt and rewire itself.

Reducing Risk of Recurrence

Ischemic stroke survivors are at an increased risk of experiencing another stroke. Early and aggressive treatment can help address underlying conditions, such as high blood pressure, cholesterol, or atherosclerosis, that contribute to the risk of recurrence. Lifestyle changes, such as quitting smoking and increasing physical activity, may also be recommended to reduce the chances of another stroke.

Saving Lives

Strokes are a leading cause of death, and prompt treatment can significantly reduce mortality rates. By seeking early treatment, patients have a higher chance of surviving the stroke and avoiding fatal complications.

In summary, early treatment for ischemic stroke is of utmost importance. It improves the chances of recovery, minimizes brain damage, enhances rehabilitation outcomes, reduces the risk of recurrence, and saves lives. When it comes to ischemic stroke, time is of the essence, and every minute counts in improving patient outcomes.

The role of tPA in restoring blood flow

Tissue plasminogen activator (tPA) is a treatment to dissolve blood clots. It is a protein that naturally occurs in the body and can be found on endothelial cells—the cells that line blood vessels. It activates the conversion of plasminogen to plasmin, an enzyme responsible for breaking down clots. This helps restore blood flow that would otherwise remain impeded.

TPA is a powerful medication that can be administered by an experienced medical team when rapid clot-busting is needed. It is given through a vein to help break up a blood clot so that blood flow can return to normal. It is used for the emergency treatment of ischemic stroke, which occurs when a blood clot interrupts blood flow to a region of the brain.

The timely administration of tPA can save lives. And because tPA restores blood flow by dissolving the clots in a blood vessel, it may limit the damage from a stroke and protect against quality of life impacts, like mobility loss or speech difficulties.

The first goal of the treatment for strokes is to restore blood flow to the affected area of the brain. The main treatment for ischemic stroke is the use of intravenous (IV) tPA, a medication that breaks up blood clots. It is most effective when given within 4 hours of the first symptoms. This treatment can’t be performed more than 5 hours after the start of the stroke.

TPA has been shown to be beneficial in the treatment of stroke, but there are risks associated with tPA treatment—even for people who have been medically cleared to receive it. It is a powerful blood thinner, and serious side effects may occur, including the following:

• Hemorrhage (bleeding) affecting the brain: Causes headaches, weakness, confusion, loss of consciousness, seizures
• Hemorrhage of the digestive system: Causes blood in the stool or stomach pain
• Severe blood loss: Causes lightheadedness, low blood pressure, loss of consciousness
• Minor bleeding in the gums or nose

The impact of stroke on brain function

The brain is a complex organ, with each part having a specific function or ability. When a stroke occurs, blood flow to a region of the brain is blocked, and that part of the brain is unable to function normally. The impact of a stroke on brain function depends on the location and extent of the damage to the brain tissue.

The brain is divided into three main areas: the cerebrum, cerebellum, and brainstem. The cerebrum, located on the right and left sides of the brain, controls movement, sensation, cognitive abilities, awareness of surroundings, and bowel and bladder control. A stroke in this area can result in paralysis, sensory loss, vision problems, and behavioural changes on the opposite side of the body.

The cerebellum, located at the back of the brain, is responsible for fine movement, coordination, and balance. Strokes in this area are less common but can lead to severe effects, including an inability to walk and trouble with balance and coordination.

The brainstem, located at the base of the brain, controls vital life functions such as heartbeat, blood pressure, and breathing, as well as eye movement, hearing, speech, chewing, and swallowing. A stroke in the brainstem can affect both sides of the body and may result in paralysis, breathing and heart function problems, and balance and coordination issues. In severe cases, a stroke in this area can lead to a 'locked-in' state, where the person is conscious but unable to move or speak.

The impact of a stroke on brain function can also depend on the type and severity of the stroke. Ischemic strokes, the most common type, are caused by blood clots or fatty deposits blocking blood flow to the brain. Hemorrhagic strokes involve the rupture of a blood vessel in the brain. Transient ischemic attacks (TIAs) or 'mini-strokes' are temporary and do not cause permanent brain damage but can be a warning sign of a more severe stroke.

The long-term effects of a stroke can include physical, emotional, and cognitive changes. Physical changes may include weakness, paralysis, vision problems, and difficulty with speaking or swallowing. Emotional changes can include depression, anxiety, irritability, and personality changes. Cognitive changes can affect memory, attention, orientation, and problem-solving abilities, as well as perception, such as how an individual sees, hears, and feels the world.

The use of mechanical thrombectomy

Mechanical thrombectomy is a minimally invasive technique used to remove blood clots from the brain after an ischemic stroke. It is performed when other treatments, such as clot-busting medications, are unsuccessful. This procedure involves making a small incision in the groin and threading thin tubes (catheters) through the blood vessels to reach the clot. A tiny device at the tip of the catheter grabs the clot and removes it, restoring blood flow to the brain.

Mechanical thrombectomy is also known as endovascular therapy and is considered gentler on the body than surgical thrombectomy. It does not require large incisions or disruption to the skull. The procedure is performed by fellowship-trained neurosurgeons specialising in endovascular techniques.

The technique is used to treat ischemic stroke, which is caused by a clot trapped in a blood vessel, preventing oxygen-rich blood from reaching the brain. There are two types of ischemic stroke: embolic stroke, where a clot from another part of the body travels to the brain, and thrombotic stroke, where a clot develops in an artery supplying blood to the brain.

During mechanical thrombectomy, an endovascular specialist makes a small incision in the groin or wrist and threads a catheter through an artery leading to the neck and brain, guided by real-time X-ray imaging. Once the clot is reached, a device called a stent retriever is inserted into the catheter and advanced past the clot. The device expands to stretch the artery walls and grab the clot, which is then removed through the artery and incision.

The procedure has been recognised for improving the chances of a good long-term outcome and has been successfully performed in patients with severe strokes, helping them regain their ability to speak and perform daily activities.

The potential for stem cell therapy

Autologous and Allogeneic Stem Cell Transplantation

Autologous stem cell transplantation involves harvesting stem cells from the patient's own body, such as from bone marrow or peripheral blood. Allogeneic transplantation, on the other hand, uses stem cells from a donor. Both approaches have been explored in the context of ischemic stroke treatment, with varying results.

Granulocyte Colony-Stimulating Factor (G-CSF)

G-CSF is a growth factor that stimulates the production of granulocytes and stem cells in the bone marrow. It has been investigated as a potential therapy for ischemic stroke, either alone or in combination with stem cell transplantation. While G-CSF has been shown to be safe, its effectiveness in improving stroke outcomes remains uncertain.

Types of Stem Cells

Different types of stem cells have been studied for their potential in ischemic stroke treatment, including:

• Mesenchymal Stem Cells (MSCs): These can be sourced from bone marrow, human umbilical cord, or adipose tissue. They have therapeutic effects, can pass through the blood-brain barrier, and have shown potential in ameliorating neurological deficits.
• Embryonic Stem Cells (ESCs): These are highly undifferentiated cells with limitless proliferation and self-renewal capabilities. They hold promise for treating central nervous system diseases but raise ethical concerns.
• Hematopoietic Stem Cells (HSCs): These can be derived from various hematopoietic tissues and have shown potential in promoting functional recovery.
• Neural Stem Cells (NSCs): These exhibit self-renewal and differentiation into neurons or glial cells. They have demonstrated the ability to promote functional recovery in mouse models of ischemic stroke.
• Induced Pluripotent Stem Cells (iPSCs): These are reprogrammed from somatic cells and have shown therapeutic effects in rat models of ischemic stroke. They address ethical concerns but have challenges like low reprogramming efficiency.

Clinical Trials

A number of clinical trials have been conducted to evaluate the safety and efficacy of stem cell therapy in ischemic stroke, with varying results:

• Some trials have shown improvements in clinical scores and functional imaging without significant adverse effects.
• Other trials have reported no significant differences in neurological outcomes or adverse events between the treatment and control groups.
• A few trials have suggested potential benefits, but larger studies are needed for validation.

Ethical Considerations

The ethical implications of stem cell therapy in stroke are significant and multifaceted, including consent, donor selection, genetic manipulation, and equitable access.

Future Directions

Future research should focus on optimizing timing and delivery methods, monitoring long-term effects, deepening the understanding of the underlying mechanisms, and addressing ethical and regulatory issues. Comparative studies are needed to identify the most effective stem cell types and combination therapies with neurorestorative techniques.

Frequently asked questions